Zeria Pharmaceutical Co., Ltd.

¥2,021As of Sun 8 Nov 2026, 12:00 UTC
TSE:4559Healthcare
Country Japan
PE (Fwd) •••
TSR 10Y CAGR 3.26%
Div yield 2.47%
ROE 10.58%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.03
PE TTM 8.344
TSR TTM 3.43%
Mkt cap ¥89.08B
ROIC 9.53%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥2,514
24.39%
17.08%
Hold 3|0|10|12|8
3Q26
4Q26
1Q27
2Q27
Earnings per share¥
37.93
36.03
35.72
36.03
20.42%
5.69%
(6.30%)
(9.59%)
Revenue¥B
9.443
9.630
9.470
9.349
(0.66%)
2.44%
(1.66%)
(3.13%)
Peers (US$565.6M)
Cap (US$)
PE
365.3M
11.06x
Capital
TTM
5Y
10Y
Leveragex
2.396
(0.232)
(0.118)
EBIT/Intx
4.646
0.143
0.131
Own earn%
47.24
54.59
55.72
Sh yield%
32.17
44.05
44.70
Owners
Insiders/Inst%
4.22
73.26
Short interest%
3.12
SBC / revenue%
5.17
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
28–33
$1 testx
—
Incr. ROIC%
1